Novo Nordisk (NVO)
(Delayed Data from NYSE)
$136.04 USD
+0.47 (0.35%)
Updated May 24, 2024 04:00 PM ET
After-Market: $136.27 +0.23 (0.17%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Brokerage Reports
0 items in cart
Novo Nordisk A/S [NVO]
Reports for Purchase
Showing records 41 - 60 ( 194 total )
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
To Bleed or Not To Bleed, That Is the $40B Question for Novel Hem-B Nonfactor Replacement Treatments
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department